Alvotech (ALVOW) Competitors $1.64 -0.06 (-3.53%) As of 06/17/2025 03:41 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrendsBuy This Stock ALVOW vs. ATNFW, LBPSW, AEHAW, AIMDW, ACABW, BFRIW, BTMDW, BCTXW, CELUW, and CINGWShould you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. Alvotech vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Cingulate Alvotech (NASDAQ:ALVOW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings. Which has stronger valuation and earnings, ALVOW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlvotech$585.60MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is ALVOW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets AlvotechN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media favor ALVOW or ATNFW? In the previous week, Alvotech had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for 180 Life Sciences. Alvotech's average media sentiment score of 0.75 beat 180 Life Sciences' score of 0.00 indicating that Alvotech is being referred to more favorably in the media. Company Overall Sentiment Alvotech Positive 180 Life Sciences Neutral Does the MarketBeat Community prefer ALVOW or ATNFW? Alvotech and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAlvotechN/AN/A180 Life SciencesN/AN/A SummaryAlvotech beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks. Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALVOW vs. The Competition Export to ExcelMetricAlvotechDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.14B$5.40B$8.60BDividend YieldN/A2.92%5.34%4.21%P/E RatioN/A4.0025.3519.19Price / SalesN/A587.37415.83113.15Price / CashN/A10.3535.3655.76Price / BookN/A7.337.786.22Net IncomeN/A$21.15B$3.15B$248.98M7 Day Performance-15.46%1.27%-2.14%-1.05%1 Month Performance-11.83%5.93%3.68%2.48%1 Year Performance-50.30%108.50%37.03%15.36% Alvotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALVOWAlvotechN/A$1.64-3.5%N/A-50.3%$0.00$585.60M0.004Positive NewsGap DownATNFW180 Life SciencesN/A$0.01-1.2%N/A-4.3%$0.00N/A0.007Positive NewsLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.02flatN/AN/A$0.00N/A0.002Gap UpAIMDWAinosN/A$0.11+8.1%N/AN/A$0.00$106.21K0.0040Positive NewsGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02+23.7%N/A-77.0%$0.00N/A0.0015Gap UpBFRIWBiofronteraN/A$0.11-12.3%N/AN/A$0.00$38.00M0.0070Positive NewsGap DownBTMDWbioteN/A$0.02-0.5%N/A-93.2%$0.00$199.38M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.10+6.4%N/A-80.8%$0.00N/A0.008News CoverageShort Interest ↑CELUWCelularityN/A$0.05+13.4%N/A+192.6%$0.00$54.22M0.00220Positive NewsGap UpCINGWCingulateN/A$0.04-18.5%N/A+397.1%$0.00N/A0.0020Positive NewsGap DownHigh Trading Volume Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Cingulate Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALVOW) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALVOW Stock Free ALVOW Stock Alerts